Most recent by Nancy Eisenberger, DNP, FNP-C
New-onset inflammatory diseases ‘may be triggered’ by COVID-19 infection, vaccination
Certain new-onset inflammatory rheumatic diseases, including polymyalgia rheumatica and vasculitis, may be triggered by SARS-CoV-2 infection or vaccination against COVID-19, according to data published in RMD Open.
Bimekizumab achieves significant, rapid improvements in axial spondyloarthritis
The use of bimekizumab to inhibit both interleukin-17A and IL-17F was well-tolerated and impactful in improving axial spondyloarthritis outcomes across two phase 3 trials, according to data published in the Annals of the Rheumatic Diseases.
Rheumatoid arthritis trials often fail to report health inequities
Randomized controlled trials for rheumatoid arthritis in Canada often fail to report determinants of health inequity among their participants, according to data published in Arthritis Care & Research.
Mobility restriction in ankylosing spondylitis occurs mainly in early years of disease
Interventions to prevent lumbar and thoracic movement restriction in patients with ankylosing spondylitis may require early intervention, as degradation seems to mainly occur in the first years of disease progression, a study found.
Intensive urate target hard to achieve with oral ULT, fails to improve erosion in gout
A more intensive serum urate target is difficult to achieve with oral urate-lowering therapy, compared with a standard target of 0.3 mmol/L, and fails to improve bone erosion scores in patients with erosive gout, according to a study.
ACR recommends booster dose of COVID-19 mRNA vaccine for patients on immunosuppressants
The American College of Rheumatology has updated its COVID-19 vaccine clinical guidance for patients with rheumatic diseases to recommend a third dose of the mRNA vaccine in those receiving immunosuppressive or immunomodulatory therapy.
COVID-19-related disruptions in rheumatology care only partly offset by telehealth
Rheumatology follow-up visit cancellations climbed to 60% during the height of the COVID-19 pandemic, and were more common for older, rural, Black and Hispanic patients, as well as those of lower socioeconomic status, according to data.
Herpes zoster more common with upadacitinib than adalimumab plus methotrexate in RA
Among patients with rheumatoid arthritis, herpes zoster is more common in those treated with upadacitinib than with adalimumab plus methotrexate or with methotrexate alone, according to a speaker at ACR Convergence 2020.
High-intensity physical activity through adolescence helps prevent osteoporosis
High-intensity physical activity throughout early life can help prevent osteoporosis and maximize peak hip strength later, according to data published in JAMA Network Open.